Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1950 1
1951 1
1952 2
1953 4
1954 4
1955 6
1956 8
1957 5
1958 3
1959 7
1960 3
1961 12
1962 24
1963 24
1964 29
1965 22
1966 20
1967 40
1968 44
1969 59
1970 49
1971 56
1972 46
1973 37
1974 44
1975 52
1976 34
1977 58
1978 62
1979 46
1980 61
1981 80
1982 90
1983 102
1984 113
1985 99
1986 141
1987 135
1988 173
1989 155
1990 144
1991 192
1992 208
1993 219
1994 227
1995 247
1996 215
1997 223
1998 272
1999 269
2000 301
2001 308
2002 311
2003 300
2004 294
2005 405
2006 369
2007 365
2008 419
2009 419
2010 405
2011 443
2012 456
2013 434
2014 534
2015 551
2016 598
2017 620
2018 666
2019 621
2020 679
2021 780
2022 694
2023 649
2024 592
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,093 results

Results by year

Filters applied: . Clear all
Page 1
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.
Meng B, Abdullahi A, Ferreira IATM, Goonawardane N, Saito A, Kimura I, Yamasoba D, Gerber PP, Fatihi S, Rathore S, Zepeda SK, Papa G, Kemp SA, Ikeda T, Toyoda M, Tan TS, Kuramochi J, Mitsunaga S, Ueno T, Shirakawa K, Takaori-Kondo A, Brevini T, Mallery DL, Charles OJ; CITIID-NIHR BioResource COVID-19 Collaboration; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ecuador-COVID19 Consortium; Bowen JE, Joshi A, Walls AC, Jackson L, Martin D, Smith KGC, Bradley J, Briggs JAG, Choi J, Madissoon E, Meyer KB, Mlcochova P, Ceron-Gutierrez L, Doffinger R, Teichmann SA, Fisher AJ, Pizzuto MS, de Marco A, Corti D, Hosmillo M, Lee JH, James LC, Thukral L, Veesler D, Sigal A, Sampaziotis F, Goodfellow IG, Matheson NJ, Sato K, Gupta RK. Meng B, et al. Among authors: sato k. Nature. 2022 Mar;603(7902):706-714. doi: 10.1038/s41586-022-04474-x. Epub 2022 Feb 1. Nature. 2022. PMID: 35104837 Free PMC article.
Einstein-de Haas Nanorotor.
Izumida W, Okuyama R, Sato K, Kato T, Matsuo M. Izumida W, et al. Among authors: sato k. Phys Rev Lett. 2022 Jan 7;128(1):017701. doi: 10.1103/PhysRevLett.128.017701. Phys Rev Lett. 2022. PMID: 35061474
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
Shimada K, Yamaguchi M, Atsuta Y, Matsue K, Sato K, Kusumoto S, Nagai H, Takizawa J, Fukuhara N, Nagafuji K, Miyazaki K, Ohtsuka E, Okamoto M, Sugita Y, Uchida T, Kayukawa S, Wake A, Ennishi D, Kondo Y, Izumi T, Kin Y, Tsukasaki K, Hashimoto D, Yuge M, Yanagisawa A, Kuwatsuka Y, Shimada S, Masaki Y, Niitsu N, Kiyoi H, Suzuki R, Tokunaga T, Nakamura S, Kinoshita T. Shimada K, et al. Among authors: sato k. Lancet Oncol. 2020 Apr;21(4):593-602. doi: 10.1016/S1470-2045(20)30059-0. Epub 2020 Mar 11. Lancet Oncol. 2020. PMID: 32171071 Clinical Trial.
Rewiring E2 enzymes.
Sato K, Knipscheer P. Sato K, et al. Nat Chem Biol. 2020 Mar;16(3):227-229. doi: 10.1038/s41589-019-0454-8. Nat Chem Biol. 2020. PMID: 31932724 No abstract available.
Protein pI and Intracellular Localization.
Tokmakov AA, Kurotani A, Sato KI. Tokmakov AA, et al. Among authors: sato ki. Front Mol Biosci. 2021 Nov 29;8:775736. doi: 10.3389/fmolb.2021.775736. eCollection 2021. Front Mol Biosci. 2021. PMID: 34912847 Free PMC article. Review.
Virological characteristics of the SARS-CoV-2 KP.3.1.1 variant.
Kaku Y, Uriu K, Okumura K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Sato K. Kaku Y, et al. Among authors: sato k. Lancet Infect Dis. 2024 Oct;24(10):e609. doi: 10.1016/S1473-3099(24)00505-X. Epub 2024 Aug 16. Lancet Infect Dis. 2024. PMID: 39159637 No abstract available.
Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236.
Fujita S, Plianchaisuk A, Deguchi S, Ito H, Nao N, Wang L, Nasser H, Tamura T, Kimura I, Kashima Y, Suzuki R, Suzuki S, Kida I, Tsuda M, Oda Y, Hashimoto R, Watanabe Y, Uriu K, Yamasoba D, Guo Z, Hinay AA Jr, Kosugi Y, Chen L, Pan L, Kaku Y, Chu H, Donati F, Temmam S, Eloit M, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Suzuki Y; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Ikeda T, Tanaka S, Matsuno K, Fukuhara T, Takayama K, Sato K. Fujita S, et al. Among authors: sato k. EBioMedicine. 2024 Jun;104:105181. doi: 10.1016/j.ebiom.2024.105181. Epub 2024 Jun 4. EBioMedicine. 2024. PMID: 38838469 Free PMC article.
Hurdles for the wide implementation of photoimmunotherapy.
Matsuoka K, Sato M, Sato K. Matsuoka K, et al. Among authors: sato k. Immunotherapy. 2021 Dec;13(17):1427-1438. doi: 10.2217/imt-2021-0241. Epub 2021 Oct 25. Immunotherapy. 2021. PMID: 34693721 Review.
Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant.
Tsujino S, Deguchi S, Nomai T, Padilla-Blanco M, Plianchaisuk A, Wang L, Begum MM, Uriu K, Mizuma K, Nao N, Kojima I, Tsubo T, Li J, Matsumura Y, Nagao M, Oda Y, Tsuda M, Anraku Y, Kita S, Yajima H, Sasaki-Tabata K, Guo Z, Hinay AA Jr, Yoshimatsu K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Nasser H, Jonathan M, Putri O, Kim Y, Chen L, Suzuki R, Tamura T, Maenaka K, Irie T, Matsuno K, Tanaka S, Ito J, Ikeda T, Takayama K, Zahradnik J, Hashiguchi T, Fukuhara T, Sato K; Genotype to Phenotype Japan (G2P‐Japan) Consortium. Tsujino S, et al. Among authors: sato k. Microbiol Immunol. 2024 Sep;68(9):305-330. doi: 10.1111/1348-0421.13165. Epub 2024 Jul 4. Microbiol Immunol. 2024. PMID: 38961765
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.
Suzuki R, Yamasoba D, Kimura I, Wang L, Kishimoto M, Ito J, Morioka Y, Nao N, Nasser H, Uriu K, Kosugi Y, Tsuda M, Orba Y, Sasaki M, Shimizu R, Kawabata R, Yoshimatsu K, Asakura H, Nagashima M, Sadamasu K, Yoshimura K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sawa H, Ikeda T, Irie T, Matsuno K, Tanaka S, Fukuhara T, Sato K. Suzuki R, et al. Among authors: sato k. Nature. 2022 Mar;603(7902):700-705. doi: 10.1038/s41586-022-04462-1. Epub 2022 Feb 1. Nature. 2022. PMID: 35104835 Free PMC article.
15,093 results
You have reached the last available page of results. Please see the User Guide for more information.